LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

Search

McKesson Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

828.06 0.15

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

825.01

Max

829.21

Pagrindiniai rodikliai

By Trading Economics

Pajamos

426M

1.2B

Pardavimai

5.3B

103B

P/E

Sektoriaus vid.

25.575

78.892

Pelnas, tenkantis vienai akcijai

9.86

Dividendų pajamingumas

0.36

Pelno marža

1.173

Darbuotojai

43,000

EBITDA

212M

1.5B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+14.01% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.36%

2.38%

Kitas uždarbis

2026-02-04

Kitas dividendų mokėjimo data

2026-01-02

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-235M

102B

Ankstesnė atidarymo kaina

827.91

Ankstesnė uždarymo kaina

828.06

Naujienos nuotaikos

By Acuity

39%

61%

114 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

McKesson Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-24 21:41; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

2025-12-24 14:57; UTC

Įsigijimai, susijungimai, perėmimai

Accenture to Acquire Cabel Industry from Fibonacci Group

2025-12-25 23:42; UTC

Rinkos pokalbiai

Nikkei May Trade in Range; Yen in Focus -- Market Talk

2025-12-25 23:40; UTC

Rinkos pokalbiai

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

2025-12-25 00:20; UTC

Įsigijimai, susijungimai, perėmimai

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

2025-12-24 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

2025-12-24 21:26; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

2025-12-24 19:35; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-24 19:35; UTC

Rinkos pokalbiai

Treasury Yields Decline Ahead of Christmas -- Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

2025-12-24 19:06; UTC

Rinkos pokalbiai

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

2025-12-24 19:03; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

2025-12-24 17:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-24 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-24 17:08; UTC

Įsigijimai, susijungimai, perėmimai

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025-12-24 16:53; UTC

Įsigijimai, susijungimai, perėmimai

Nike Climb Boosts Dow, S&P 500 -- WSJ

2025-12-24 16:31; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

2025-12-24 16:28; UTC

Įsigijimai, susijungimai, perėmimai

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

2025-12-24 16:17; UTC

Rinkos pokalbiai

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

2025-12-24 15:33; UTC

Įsigijimai, susijungimai, perėmimai

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

2025-12-24 15:30; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 15:19; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 14:49; UTC

Įsigijimai, susijungimai, perėmimai

Mexico's Ollamani Sells Stake in Azteca Stadium

2025-12-24 14:19; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

2025-12-24 14:08; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 14:06; UTC

Rinkos pokalbiai

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

2025-12-24 13:24; UTC

Rinkos pokalbiai

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

2025-12-24 12:59; UTC

Įsigijimai, susijungimai, perėmimai

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025-12-24 12:51; UTC

Įsigijimai, susijungimai, perėmimai

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

McKesson Corp Prognozė

Kainos tikslas

By TipRanks

14.01% į viršų

12 mėnesių prognozė

Vidutinis 942.18 USD  14.01%

Aukščiausias 1,000 USD

Žemiausias 880 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines McKesson Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

12

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

681.92 / 707.28Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

No Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

114 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat